Authors: BERRY G BILLINGHAM M ALDERMAN E RICHARDSON P TORTI F LUM B PATEK A MARTIN FJ

Citation: G. Berry et al., THE USE OF CARDIAC BIOPSY TO DEMONSTRATE REDUCED CARDIOTOXICITY IN AIDS-KAPOSIS SARCOMA PATIENTS TREATED WITH PEGYLATED LIPOSOMAL DOXORUBICIN, Annals of oncology, 9(7), 1998, pp. 711-716

Authors: ADVANI R SABA HI TALLMAN M ROWE JM WIERNIK PH RAMEK J DUGAN K LUM B VILLENA J SIKIC BI DAVIS E PAIETTA E LITCHMAN M GREENBERG P

Citation: R. Advani et al., TREATMENT OF POOR-PROGNOSIS AML WITH PSC833 PLUS MITOXANTRONE, ETOPOSIDE, CYTARABINE (PSC-MEC), Blood, 90(10), 1997, pp. 2260-2260

Authors: GOSLAND M LUM B SCHIMMELPFENNIG J BAKER J DOUKAS M

Citation: M. Gosland et al., INSIGHTS INTO MECHANISMS OF CISPLATIN RESISTANCE AND POTENTIAL FOR ITS CLINICAL REVERSAL, Pharmacotherapy, 16(1), 1996, pp. 16-39

Authors: MOCHON M COONEY G LUM B CAPUTO GC DUNN S GOLDSMITH B BALUARTE HJ POLINSKY MS KAISER BA

Citation: M. Mochon et al., PHARMACOKINETICS OF CYCLOSPORINE AFTER RENAL-TRANSPLANT IN CHILDREN, Journal of clinical pharmacology, 36(7), 1996, pp. 580-586

Authors: ADVANI R SABA H ROWE JM TALLMAN M WIERNIK P RAMEK J DUGAN K LITCHMAN M DORR R LUM B SIKIC B DAVIS E PAIETTA E GREENBERG P

Citation: R. Advani et al., TREATMENT OF REFRACTORY RELAPSED AML WITH PSC833 PLUS MITOXANTRONE, ETOPOSIDE, CYTARABINE (PSC-MEC)/, Blood, 88(10), 1996, pp. 847-847